These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24633120)

  • 1. Procalcitonin or C-reactive protein: that is the question?
    Corona A; De Iaco M
    Crit Care Med; 2014 Apr; 42(4):e310-1. PubMed ID: 24633120
    [No Abstract]   [Full Text] [Related]  

  • 2. The authors reply.
    Nobre V; Oliveira CF; Oliveira CR
    Crit Care Med; 2014 Apr; 42(4):e311-2. PubMed ID: 24633121
    [No Abstract]   [Full Text] [Related]  

  • 3. The authors reply.
    Nobre V; Oliveira CF; de Oliveira CR
    Crit Care Med; 2014 Feb; 42(2):e173. PubMed ID: 24434474
    [No Abstract]   [Full Text] [Related]  

  • 4. Chipping away at unnecessary antibiotic use in the ICU, one day and one study at a time.
    Fraimow HS
    Crit Care Med; 2013 Oct; 41(10):2447-8. PubMed ID: 24060778
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials of biomarker-guided antimicrobial therapy in sepsis: improvements in trial design require better control groups.
    Salluh JI; Póvoa P
    Crit Care Med; 2014 Feb; 42(2):e172. PubMed ID: 24434473
    [No Abstract]   [Full Text] [Related]  

  • 6. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
    Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
    Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-guided therapy in severe sepsis and septic shock. Authors' response.
    Schlattmann P; Brunkhorst FM
    Crit Care; 2014 May; 18(3):427. PubMed ID: 25473656
    [No Abstract]   [Full Text] [Related]  

  • 8. Procalcitonin-guided therapy in severe sepsis and septic shock.
    Gu WJ; Liu JC
    Crit Care; 2014 May; 18(3):427. PubMed ID: 25033407
    [No Abstract]   [Full Text] [Related]  

  • 9. Procalcitonin as a biomarker for toxic shock syndrome.
    Kato M; Kaneko S; Takagaki K; Kohayagawa Y; Watanabe T; Yoshida Y; Yamamoto O
    Acta Derm Venereol; 2010 Jul; 90(4):441-3. PubMed ID: 20574626
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units].
    Průcha M; Herold I; Zazula R; Dubská L; Kavka B; Dostál M
    Vnitr Lek; 2003 Jul; 49(7):541-7. PubMed ID: 12931436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock].
    Suberviola B; Castellanos-Ortega A; González-Castro A; García-Astudillo LA; Fernández-Miret B
    Med Intensiva; 2012 Apr; 36(3):177-84. PubMed ID: 22055776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked elevation of procalcitonin level can lead to a misdiagnosis of anaphylactic shock as septic shock.
    Kim YJ; Kang SW; Lee JH; Cho JH
    Int J Infect Dis; 2015 Aug; 37():93-4. PubMed ID: 26119856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of procalcitonin. Valuable for reducing ineffective antibiotic use is debatable].
    Damoiseaux RA
    Ned Tijdschr Geneeskd; 2009 Feb; 153(7):268-9. PubMed ID: 19291938
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic value of procalcitonin in severe sepsis and septic shock].
    Julián-Jiménez A; Laserna-Mendieta EJ; Timón-Zapata J; Pedrosa Guerrero A
    Med Intensiva; 2013 Mar; 37(2):123-4. PubMed ID: 23290924
    [No Abstract]   [Full Text] [Related]  

  • 15. Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers.
    Salluh JI; Nobre V; Povoa P
    Crit Care; 2014 May; 18(3):142. PubMed ID: 25032999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
    Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
    Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.
    Uzzan B; Cohen R; Nicolas P; Cucherat M; Perret GY
    Crit Care Med; 2006 Jul; 34(7):1996-2003. PubMed ID: 16715031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical research of timing of application of antibiotics in septic shock of pediatric patients].
    Wang XD; Huo XM; Xu MX; Geng WJ; Guo YM; Cao LJ; Sun H; Shi XN; Li JE; Shi HY; Li P; Kang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Apr; 25(4):207-10. PubMed ID: 23660095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
    Albrich WC; Harbarth S
    Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.